DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION

Allogeneic stem cell transplantation (alloHSCT) is effective curative option for a broad range of primary immunodeficiencies (PIDs). Hematopoietic chimerism monitoring in patients with various PIDs and its connection with the outcome of alloHSCT is of great interest. In this study 16 alloHSCT in pat...

Full description

Bibliographic Details
Main Authors:	V. A. Lavrinenko, Y. E. Marejco, E. Y. Berezovskaya, M. V. Stegantseva, N. V. Minakowskaja, M. V. Belevtsev
Format:	Article
Language:	Russian
Published:	ABV-press 2018-07-01
Series:	Onkogematologiâ
Subjects:	chimerism white blood cell subpopulations primary immunodeficiency allogeneic stem cell transplantation graft-versus-host disease immune reconstitution children
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/292

Similar Items

Quimerismo molecular en el trasplante alogénico de células hematopoyéticas: Resultados preliminares Molecular chimerism in the allogeneic transplantation of hematopoietic cells: Preliminary results
Published: (2005-12-01)

Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation
by: Tanja Stahl, et al.
Published: (2016-09-01)

Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantation
by: Shigeo eFuji, et al.
Published: (2013-09-01)

Low Level Donor Chimerism of CD19 CAR-T Cells Returned to Complete Donor Chimerism in Patients with Relapse After Allo-Hematopoietic Stem Cell Transplant
by: Li Q, et al.
Published: (2020-11-01)

Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
by: Katrine Kielsen, et al.
Published: (2018-02-01)

Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation
by: Martin Solders, et al.
Published: (2017-12-01)

Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
by: Linde Dekker, et al.
Published: (2020-07-01)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Nataliya Prokopenko Buxbaum, et al.
Published: (2020-08-01)

An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation
by: Hana Andrlová, et al.
Published: (2021-02-01)

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
by: Jean-Marc Hoffmann, et al.
Published: (2018-01-01)

Treatment of acute host-versus-graft reaction in patients after allogeneic hematopoietic cell transplantation with multipotent mesenchymal stromal cells from a bone marrow donor
by: N A Petinati, et al.
Published: (2012-07-01)

Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation
by: MYu Drokov, et al.
Published: (2019-12-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases
by: Kristin Gerhardt, et al.
Published: (2021-09-01)

Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation
by: Richard J. Lin, et al.
Published: (2021-04-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

Adult aplastic anemia patients can maintain remission after allogeneic hematopoietic stem cell transplantation in a mixed chimeric state
by: Fevzi Altuntaş, et al.
Published: (2020-09-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation
by: Hideaki Fujiwara
Published: (2021-08-01)

Efficacy and safety of prophylactic modified donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
by: YANG Luxin, et al.
Published: (2019-12-01)

Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting
by: Martyna Tyszka, et al.
Published: (2021-06-01)

Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant
by: R.C.V. Carrara, et al.
Published: (2007-01-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center
by: Mei-Fang Hou, et al.
Published: (2015-03-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant
by: Pengjiang Liu, et al.
Published: (2020-09-01)

Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
by: Reena Kumari, et al.
Published: (2020-11-01)

Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion
by: Lisa C. Kadyk, et al.
Published: (2020-09-01)

Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study
by: Ling Wang, et al.
Published: (2021-02-01)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
by: Ana Marcela Rojas Fonseca-Hial, et al.
Published: (2016-06-01)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
by: Ariadna Bartoló-Ibars, et al.
Published: (2021-09-01)

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease
by: Maud D’Aveni, et al.
Published: (2021-02-01)

Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation
by: O A Slesarchuk, et al.
Published: (2013-07-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
by: Kunadt D, et al.
Published: (2021-09-01)